Literature DB >> 10780963

Histamine H(3)-receptor antagonists inhibit gastroprotection by (R)-alpha-methylhistamine in the rat.

G Morini1, D Grandi, H Stark, W Schunack.   

Abstract

(R)-alpha-methylhistamine, a selective agonist of histamine H(3) receptors, is capable of protecting the gastric mucosa against differently acting damaging agents. The objective of the present study was to determine whether H(3) receptors mediate its protective action in the rat. Gastric mucosal lesions were induced intragastrically (i.g.) by 0.6 N HCl, 1 ml rat(-1). (R)-alpha-methylhistamine, 100 mg kg(-1) i.g., substantially reduced the severity of macroscopically and histologically assessed damage caused by concentrated acid. Prior treatment with highly selective H(3)-receptor antagonists, ciproxifan (0.3, 1 and 3 mg kg(-1) i.g.) and clobenpropit (3, 10 and 30 mg kg(-1) i.g.), dose-dependently inhibited the protection exerted by (R)-alpha-methylhistamine up to a complete reversal. When given alone at high doses, both antagonists tended to worsen the HCl-induced histologic damage. During basal conditions, (R)-alpha-methylhistamine, 100 mg kg(-1) i. g., caused a significant increase in titratable acidity of the gastric juice. Prior treatment with ciproxifan (3 mg kg(-1) i.g.) and clobenpropit (30 mg kg(-1) i.g.) did not alter the secretory response to (R)-alpha-methylhistamine. Clobenpropit alone, but not ciproxifan, increased the volume of gastric juice, and both compounds alone had no effect on titratable acid. Present findings support evidence that H(3) receptors are actively involved in the maintenance of gastric mucosal integrity, with no apparent role in the regulation of basal gastric acid secretion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780963      PMCID: PMC1572006          DOI: 10.1038/sj.bjp.0703249

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  In vivo demonstration of H3-histaminergic inhibition of cardiac sympathetic stimulation by R-alpha-methyl-histamine and its prodrug BP 2.94 in the dog.

Authors:  C Mazenot; C Ribuot; A Durand; Y Joulin; P Demenge; D Godin-Ribuot
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  Gastric mucosal injury by nonsteroidal anti-inflammatory drugs is reduced by (R)-alpha-methylhistamine and its pro-drugs in the rat.

Authors:  G Morini; D Grandi; M Krause; W Schunack
Journal:  Inflamm Res       Date:  1997-03       Impact factor: 4.575

3.  Brain penetration of the histamine H3 receptor antagonists thioperamide and clobenpropit in rat and mouse, determined with ex vivo [125I]iodophenpropit binding.

Authors:  T Mochizuki; F P Jansen; R Leurs; A D Windhorst; A Yamatodani; K Maeyama; H Timmerman
Journal:  Brain Res       Date:  1996-12-16       Impact factor: 3.252

4.  Inhibitory H3 receptors on sympathetic nerves of the pithed rat: activation by endogenous histamine and operation in spontaneously hypertensive rats.

Authors:  G Godlewski; B Malinowska; W Buczko; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1997-02       Impact factor: 3.000

5.  Stereoselective inhibition of ethanol-induced gastric lesions in the rat by the H(3)-receptor agonist (R)-alpha-methylhistamine and its (S)-configured isomer.

Authors:  G Morini; D Grandi; G Bertaccini; C Leschke; W Schunack
Journal:  Pharmacology       Date:  1999-10       Impact factor: 2.547

6.  Effect of clobenpropit, a centrally acting histamine H3-receptor antagonist, on electroshock- and pentylenetetrazol-induced seizures in mice.

Authors:  W Fischer; H van der Goot
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

7.  Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.

Authors:  X Ligneau; J Lin; G Vanni-Mercier; M Jouvet; J L Muir; C R Ganellin; H Stark; S Elz; W Schunack; J Schwartz
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

8.  Stereoselectivity of the histamine H3-presynaptic autoreceptor.

Authors:  J M Arrang; J C Schwartz; W Schunack
Journal:  Eur J Pharmacol       Date:  1985-10-29       Impact factor: 4.432

9.  Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice.

Authors:  H Yokoyama; K Onodera; K Maeyama; E Sakurai; K Iinuma; R Leurs; H Timmerman; T Watanabe
Journal:  Eur J Pharmacol       Date:  1994-07-21       Impact factor: 4.432

10.  Pharmacological activity of VUF 9153, an isothiourea histamine H3 receptor antagonist.

Authors:  J C Barnes; J D Brown; N P Clarke; J Clapham; D J Evans; C T O'Shaughnessy
Journal:  Eur J Pharmacol       Date:  1993-11-30       Impact factor: 4.432

View more
  3 in total

1.  Ligands for histamine H(3) receptors modulate cell proliferation and migration in rat oxyntic mucosa.

Authors:  Giuseppina Morini; Daniela Grandi; Walter Schunack
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 2.  New molecular targets for treatment of peptic ulcer disease.

Authors:  Frank Lehmann; Pius Hildebrand; Christoph Beglinger
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Influence of the Novel Histamine H3 Receptor Antagonist/Inverse Agonist M39 on Gastroprotection and PGE2 Production Induced by (R)-Alpha-Methylhistamine in C57BL/6 Mice.

Authors:  Salim M A Bastaki; Naheed Amir; Małgorzata Więcek; Katarzyna Kieć-Kononowicz; Bassem Sadek
Journal:  Front Pharmacol       Date:  2019-09-12       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.